The cleaned title from the string Executive-Engineering is Executive Engineering .

Jubilant Pharma Limited is a global integrated pharmaceutical company that offers a wide range of products and services to customers across various geographies. The business is organized into two segments: Specialty Pharmaceuticals and Generics & APIs. Specialty Pharmaceuticals segment includes Radiopharmaceuticals, Contract Manufacturing of Sterile Injectable, Non-sterile & Allergy Therapy Products. Generics & APIs segment comprises Solid Dosage Formulations & Active Pharmaceutical Ingredients. Jubilant Generics (JGL) is a wholly-owned subsidiary of Jubilant Pharma with Research & Development units in Noida and Mysore, India. It operates two manufacturing facilities in Mysore, Karnataka, and Roorkee, Uttarakhand, focusing on APIs and Dosage manufacturing. The Mysore manufacturing site, spread over 69 acres, is a USFDA approved facility catering to global sales with a portfolio concentrating on Lifestyle-driven Therapeutic Areas like CVS, CNS. The Roorkee facility is state-of-the-art and approved by multiple regulatory bodies including USFDA, Japan PMDA, UK MHRA, TGA, WHO, and Brazil ANVISA, following a B2B model for EU, Canada, and emerging markets. Both manufacturing units are backward-integrated and supported by approximately 500 research and development professionals in Noida and Mysore. R&D efforts include developing new products in API, Solid Dosage Formulations, Sterile Injectable, Semi-Solids Ointments, Creams, and Liquids. JGL's Regulatory Affairs & IPR professionals maintain a unique portfolio of patents and product filings in regulatory and non-regulatory markets. Jubilant Pharma's revenue has been consistently growing, reaching INR 53,240 Million during the Financial Year 2018-19 compared to INR 39,950 Million in the Financial Year 2017-18. For more information about the organization, please visit www.jubilantpharma.com.,